bcbs michigan glp-1 Blue Cross Blue Shield of Mass. sees gains after years of GLP-1-related losses GLP-1 Drugs Could Raise Employer

We start every journey with a full You Review so we can understand your unique goals and how to achieve them

I found this really intriguing because before I was diagnosed with PA and treated with B12 injections, I was heading down the path of gastroparesis

Pfizer, after discontinuing its initial danuglipron candidate due to safety concerns in April 2025, re-entered the race through a $10 billion acquisition of clinical-stage biotech Metsera in November 2025, securing a next-generation obesity pipeline [43]

If you want medication and support from a single provider, Second Nature does both

So for those of you with filler, this is a MUST HAVE for between appointments